Home › Companies › Solid Biosciences Inc. › 2025-2026
Compiled from SEC Form N-PX filings and Solid Biosciences Inc.’s Form 8-K, filed June 10, 2026 (Item 5.07 on EDGAR). Page generated October 25, 2026.
Meeting of June 10, 2026: 7 items on Solid Biosciences Inc.’s Form 8-K, filed June 10, 2026: 3 elected · 4 approved.
None.
Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided
Proxy season: 2024-2025 2025-2026
Explore Solid Biosciences Inc. in the interactive database Compare manager voting policies
These tallies are Solid Biosciences Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 10, 2026 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Clare Kahn | 73,139,200 | -- | -- | 5,700,169 | 7,685,551 | 93% | Elected | — |
| Elect Director: Adam Stone | 71,556,735 | -- | -- | 7,282,634 | 7,685,551 | 91% | Elected | — |
| Elect Director: Lynne Sullivan | 73,124,331 | -- | -- | 5,715,038 | 7,685,551 | 93% | Elected | — |
| 2. The appointment of Ilan Ganot, on an advisory basis, as a Class I director to serve until the 2028 Annual Meeting of Stockholders | 78,636,398 | 185,585 | 17,386 | -- | 7,685,551 | 99.7% | Approved | — |
| 3. The appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026 | 86,420,186 | 70,007 | 34,727 | -- | -- | 99.9% | Approved | — |
| 4. An amendment to the Company's Certificate of Incorporation, as amended, to increase the number of authorized shares of the Company's common stock from 240,000,000 to 480,000,000 (the "Share Increase Amendment") | 85,604,508 | 893,360 | 27,502 | -- | -- | 99% | Approved | — |
| 5. The non-binding, advisory vote on the compensation paid to its named executive officers | 72,596,980 | 6,203,634 | 38,755 | -- | 7,685,551 | 92% | Approved | — |
Source: Solid Biosciences Inc., Form 8-K, filed with the SEC on June 10, 2026 — read the filing on EDGAR.
Each item below shows how the 150 asset managers that disclosed a Solid Biosciences Inc. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 3 wordings of this item as funds reported it.
91% Majority: yes · of votes cast
Description as filed by funds: Election of Class II Directors: Adam Stone
Solid Biosciences Inc.’s own tally for this item (“Elect Director: Adam Stone”): 71,556,735 for, 7,282,634 withheld, per its Form 8-K filed June 10, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The Company's stockholders elected Clare Kahn, Adam Stone and Lynne Sullivan as Class II directors to serve until the 2029 Annual Meeting of Stockholders, each director to hold office until his or her successor has been duly appointed and qualified.”
Support: 91% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 44 asset managers below reported 13,357,348 for, 591,259 withheld, 7 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 4,839,219 | 0 | 0 | 0 | For |
| Vanguard | 2,980,065 | 0 | 7 | 5,422 | For |
| Columbia Threadneedle | 1,595,479 | 0 | 0 | 0 | For |
| BlackRock | 1,487,648 | 0 | 0 | 44,895 | For |
| FRANKLIN STRATEGIC SERIES | 1,253,978 | 0 | 0 | 0 | For |
| TIAA | 387,214 | 0 | 0 | 0 | For |
| Invesco | 231,907 | 0 | 0 | 0 | For |
| Charles Schwab | 160,725 | 0 | 0 | 0 | For |
| Equitable | 97,235 | 0 | 0 | 52,080 | Mixed |
| American Century | 0 | 0 | 0 | 114,392 | Withhold |
| Dimensional | 0 | 0 | 0 | 97,394 | Withhold |
| QUANTITATIVE MASTER SERIES LLC | 97,015 | 0 | 0 | 0 | For |
| JPMorgan | 94,041 | 0 | 0 | 0 | For |
| Lincoln Financial | 20,678 | 0 | 0 | 64,078 | Mixed |
| Northern Trust | 0 | 0 | 0 | 29,404 | Withhold |
| Global X | 28,094 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 27,766 | 0 | 0 | 0 | For |
| Voya | 0 | 0 | 0 | 23,575 | Withhold |
| MASTER INVESTMENT PORTFOLIO | 0 | 0 | 0 | 22,095 | Withhold |
| Pacific Life | 21,916 | 0 | 0 | 0 | For |
| Nationwide | 16,998 | 0 | 0 | 2,409 | Mixed |
| State Street | 0 | 0 | 0 | 19,329 | Withhold |
| BRIDGEWAY FUNDS INC | 0 | 0 | 0 | 15,000 | Withhold |
| Brighthouse | 0 | 0 | 0 | 14,782 | Withhold |
| Jackson National | 0 | 0 | 0 | 13,761 | Withhold |
Showing the 25 largest of 44 asset managers. See all 44 in the interactive database.
Combines 3 wordings of this item as funds reported it.
93% Majority: yes · of votes cast
Description as filed by funds: Election of Class II Directors: Clare Kahn
Solid Biosciences Inc.’s own tally for this item (“Elect Director: Clare Kahn”): 73,139,200 for, 5,700,169 withheld, per its Form 8-K filed June 10, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The Company's stockholders elected Clare Kahn, Adam Stone and Lynne Sullivan as Class II directors to serve until the 2029 Annual Meeting of Stockholders, each director to hold office until his or her successor has been duly appointed and qualified.”
Support: 93% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 44 asset managers below reported 13,540,791 for, 407,817 withheld, 6 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 4,839,219 | 0 | 0 | 0 | For |
| Vanguard | 2,981,826 | 0 | 6 | 3,662 | For |
| Columbia Threadneedle | 1,595,479 | 0 | 0 | 0 | For |
| BlackRock | 1,532,543 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 1,253,978 | 0 | 0 | 0 | For |
| TIAA | 387,214 | 0 | 0 | 0 | For |
| Invesco | 231,907 | 0 | 0 | 0 | For |
| Charles Schwab | 160,725 | 0 | 0 | 0 | For |
| Equitable | 97,235 | 0 | 0 | 52,080 | Mixed |
| American Century | 0 | 0 | 0 | 114,392 | Withhold |
| Dimensional | 0 | 0 | 0 | 97,394 | Withhold |
| QUANTITATIVE MASTER SERIES LLC | 97,015 | 0 | 0 | 0 | For |
| JPMorgan | 94,041 | 0 | 0 | 0 | For |
| Lincoln Financial | 57,278 | 0 | 0 | 27,478 | Mixed |
| Northern Trust | 29,404 | 0 | 0 | 0 | For |
| Global X | 28,094 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 27,766 | 0 | 0 | 0 | For |
| Voya | 23,575 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 22,095 | 0 | 0 | 0 | For |
| Pacific Life | 21,916 | 0 | 0 | 0 | For |
| Nationwide | 19,407 | 0 | 0 | 0 | For |
| State Street | 19,329 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 0 | 0 | 0 | 15,000 | Withhold |
| Brighthouse | 0 | 0 | 0 | 14,782 | Withhold |
| Jackson National | 0 | 0 | 0 | 13,761 | Withhold |
Showing the 25 largest of 44 asset managers. See all 44 in the interactive database.
Combines 3 wordings of this item as funds reported it.
93% Majority: yes · of votes cast
Description as filed by funds: Election of Class II Directors: Lynne Sullivan
Solid Biosciences Inc.’s own tally for this item (“Elect Director: Lynne Sullivan”): 73,124,331 for, 5,715,038 withheld, per its Form 8-K filed June 10, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The Company's stockholders elected Clare Kahn, Adam Stone and Lynne Sullivan as Class II directors to serve until the 2029 Annual Meeting of Stockholders, each director to hold office until his or her successor has been duly appointed and qualified.”
Support: 93% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 44 asset managers below reported 13,539,031 for, 409,577 withheld, 6 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 4,839,219 | 0 | 0 | 0 | For |
| Vanguard | 2,980,066 | 0 | 6 | 5,422 | For |
| Columbia Threadneedle | 1,595,479 | 0 | 0 | 0 | For |
| BlackRock | 1,532,543 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 1,253,978 | 0 | 0 | 0 | For |
| TIAA | 387,214 | 0 | 0 | 0 | For |
| Invesco | 231,907 | 0 | 0 | 0 | For |
| Charles Schwab | 160,725 | 0 | 0 | 0 | For |
| Equitable | 97,235 | 0 | 0 | 52,080 | Mixed |
| American Century | 0 | 0 | 0 | 114,392 | Withhold |
| Dimensional | 0 | 0 | 0 | 97,394 | Withhold |
| QUANTITATIVE MASTER SERIES LLC | 97,015 | 0 | 0 | 0 | For |
| JPMorgan | 94,041 | 0 | 0 | 0 | For |
| Lincoln Financial | 57,278 | 0 | 0 | 27,478 | Mixed |
| Northern Trust | 29,404 | 0 | 0 | 0 | For |
| Global X | 28,094 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 27,766 | 0 | 0 | 0 | For |
| Voya | 23,575 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 22,095 | 0 | 0 | 0 | For |
| Pacific Life | 21,916 | 0 | 0 | 0 | For |
| Nationwide | 19,407 | 0 | 0 | 0 | For |
| State Street | 19,329 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 0 | 0 | 0 | 15,000 | Withhold |
| Brighthouse | 0 | 0 | 0 | 14,782 | Withhold |
| Jackson National | 0 | 0 | 0 | 13,761 | Withhold |
Showing the 25 largest of 44 asset managers. See all 44 in the interactive database.
Combines 2 wordings of this item as funds reported it.
99.7% Approved · of votes cast
Description as filed by funds: The ratification of the appointment of Ilan Ganot, on an advisory basis, to the Company's Board of Directors as a Class I Director to hold office until the 2028 annual meeting of stockholders.
Solid Biosciences Inc.’s own tally for this item (“2. The appointment of Ilan Ganot, on an advisory basis, as a Class I director to serve until the 2028 Annual Meeting of Stockholders”): 78,636,398 for, 185,585 against — passed, per its Form 8-K filed June 10, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The Company's stockholders ratified the appointment of Ilan Ganot, on an advisory basis, as a Class I director to serve until the 2028 Annual Meeting of Stockholders.”
Support: 99.7% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 44 asset managers below reported 13,944,952 for, 3,662 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 4,839,219 | 0 | 0 | 0 | For |
| Vanguard | 2,981,832 | 3,662 | 0 | 0 | For |
| Columbia Threadneedle | 1,595,479 | 0 | 0 | 0 | For |
| BlackRock | 1,532,543 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 1,253,978 | 0 | 0 | 0 | For |
| TIAA | 387,214 | 0 | 0 | 0 | For |
| Invesco | 231,907 | 0 | 0 | 0 | For |
| Charles Schwab | 160,725 | 0 | 0 | 0 | For |
| Equitable | 149,315 | 0 | 0 | 0 | For |
| American Century | 114,392 | 0 | 0 | 0 | For |
| Dimensional | 97,394 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 97,015 | 0 | 0 | 0 | For |
| JPMorgan | 94,041 | 0 | 0 | 0 | For |
| Lincoln Financial | 84,756 | 0 | 0 | 0 | For |
| Northern Trust | 29,404 | 0 | 0 | 0 | For |
| Global X | 28,094 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 27,766 | 0 | 0 | 0 | For |
| Voya | 23,575 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 22,095 | 0 | 0 | 0 | For |
| Pacific Life | 21,916 | 0 | 0 | 0 | For |
| Nationwide | 19,407 | 0 | 0 | 0 | For |
| State Street | 19,329 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 15,000 | 0 | 0 | 0 | For |
| Brighthouse | 14,782 | 0 | 0 | 0 | For |
| Jackson National | 13,761 | 0 | 0 | 0 | For |
Showing the 25 largest of 44 asset managers. See all 44 in the interactive database.
99% Approved · of votes cast
Description as filed by funds: The approval of an amendment to the Company's Certificate of Incorporation, as amended, to increase the number of authorized shares of the Company's common stock from 240,000,000 to 480,000,000.
Solid Biosciences Inc.’s own tally for this item (“4. An amendment to the Company's Certificate of Incorporation, as amended, to increase the number of authorized shares of the Company's common stock from 240,000,000 to 480,000,000 (the "Share Increase Amendment")”): 85,604,508 for, 893,360 against — passed, per its Form 8-K filed June 10, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The Company's stockholders approved an amendment to the Company's Certificate of Incorporation, as amended, to increase the number of authorized shares of the Company's common stock from 240,000,000 to 480,000,000 (the "Share Increase Amendment").”
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 44 asset managers below reported 13,948,613 for, 1 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 4,839,219 | 0 | 0 | 0 | For |
| Vanguard | 2,985,493 | 1 | 0 | 0 | For |
| Columbia Threadneedle | 1,595,479 | 0 | 0 | 0 | For |
| BlackRock | 1,532,543 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 1,253,978 | 0 | 0 | 0 | For |
| TIAA | 387,214 | 0 | 0 | 0 | For |
| Invesco | 231,907 | 0 | 0 | 0 | For |
| Charles Schwab | 160,725 | 0 | 0 | 0 | For |
| Equitable | 149,315 | 0 | 0 | 0 | For |
| American Century | 114,392 | 0 | 0 | 0 | For |
| Dimensional | 97,394 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 97,015 | 0 | 0 | 0 | For |
| JPMorgan | 94,041 | 0 | 0 | 0 | For |
| Lincoln Financial | 84,756 | 0 | 0 | 0 | For |
| Northern Trust | 29,404 | 0 | 0 | 0 | For |
| Global X | 28,094 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 27,766 | 0 | 0 | 0 | For |
| Voya | 23,575 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 22,095 | 0 | 0 | 0 | For |
| Pacific Life | 21,916 | 0 | 0 | 0 | For |
| Nationwide | 19,407 | 0 | 0 | 0 | For |
| State Street | 19,329 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 15,000 | 0 | 0 | 0 | For |
| Brighthouse | 14,782 | 0 | 0 | 0 | For |
| Jackson National | 13,761 | 0 | 0 | 0 | For |
Showing the 25 largest of 44 asset managers. See all 44 in the interactive database.
Combines 5 wordings of this item as funds reported it.
92% Approved · of votes cast
Description as filed by funds: THE APPROVAL OF AN ADVISORY VOTE ON EXECUTIVE COMPENSATION.
Solid Biosciences Inc.’s own tally for this item (“5. The non-binding, advisory vote on the compensation paid to its named executive officers”): 72,596,980 for, 6,203,634 against — passed, per its Form 8-K filed June 10, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The Company's stockholders approved the non-binding, advisory vote on the compensation paid to its named executive officers.”
Support: 92% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 4,839,219 | 0 | 0 | 0 | For |
| Vanguard | 2,985,488 | 6 | 0 | 0 | For |
| Columbia Threadneedle | 1,595,479 | 0 | 0 | 0 | For |
| BlackRock | 1,532,543 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 1,253,978 | 0 | 0 | 0 | For |
| TIAA | 387,214 | 0 | 0 | 0 | For |
| Invesco | 0 | 231,907 | 0 | 0 | Against |
| Charles Schwab | 160,725 | 0 | 0 | 0 | For |
| Equitable | 97,235 | 52,080 | 0 | 0 | Mixed |
| American Century | 0 | 114,392 | 0 | 0 | Against |
| Dimensional | 0 | 97,394 | 0 | 0 | Against |
| QUANTITATIVE MASTER SERIES LLC | 97,015 | 0 | 0 | 0 | For |
| JPMorgan | 94,041 | 0 | 0 | 0 | For |
| Lincoln Financial | 57,278 | 27,478 | 0 | 0 | Mixed |
| Northern Trust | 29,404 | 0 | 0 | 0 | For |
| Global X | 28,094 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 27,766 | 0 | 0 | 0 | For |
| Voya | 0 | 23,575 | 0 | 0 | Against |
| MASTER INVESTMENT PORTFOLIO | 22,095 | 0 | 0 | 0 | For |
| Pacific Life | 21,916 | 0 | 0 | 0 | For |
| Nationwide | 19,407 | 0 | 0 | 0 | For |
| State Street | 19,329 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 0 | 15,000 | 0 | 0 | Against |
| Brighthouse | 0 | 14,782 | 0 | 0 | Against |
| Jackson National | 0 | 13,761 | 0 | 0 | Against |
Fund voting reports, all 44 managers: 13,309,711 for, 638,903 against. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| PERCEPTIVE ADVISORS LLC | 11,055,900 | 0 | 0 | 0 | For |
| RA CAPITAL MANAGEMENT, L.P. | 9,339,978 | 0 | 0 | 0 | For |
| Siren, L.L.C. | 7,690,405 | 0 | 0 | 0 | For |
| Bain Capital Life Sciences Investors, LLC | 4,505,922 | 0 | 0 | 0 | For |
| Fidelity | 3,730,575 | 0 | 0 | 0 | For |
| Deep Track Capital, LP | 3,565,062 | 0 | 0 | 0 | For |
| FRANKLIN ADVISERS INC | 2,649,449 | 22,467 | 0 | 0 | For |
| Vestal Point Capital, LP | 0 | 2,505,604 | 0 | 0 | Against |
| Redmile Group, LLC | 1,948,695 | 0 | 0 | 0 | For |
| BlackRock | 1,792,854 | 11,607 | 0 | 0 | For |
| Alyeska Investment Group, L.P. | 1,652,985 | 0 | 0 | 0 | For |
| Citadel | 1,386,584 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 1,304,495 | 0 | 0 | 0 | For |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 582,400 | 537,600 | 0 | 0 | Mixed |
| State Street | 933,646 | 7,056 | 0 | 0 | For |
| ARMISTICE CAPITAL, LLC | 550,935 | 0 | 0 | 0 | For |
| SILVERARC CAPITAL MANAGEMENT, LLC | 0 | 535,377 | 0 | 0 | Against |
| Woodline Partners LP | 479,795 | 0 | 0 | 0 | For |
| Nantahala Capital Management, LLC | 478,889 | 0 | 0 | 0 | For |
| BLAIR WILLIAM & CO/IL | 0 | 441,200 | 0 | 0 | Against |
| Nuveen | 400,292 | 0 | 0 | 0 | For |
| Vanguard | 362,451 | 4,783 | 0 | 0 | For |
| Ally Bridge Group (NY) LLC | 358,257 | 0 | 0 | 0 | For |
| Northern Trust | 312,698 | 9,174 | 0 | 0 | For |
| AMERIPRISE FINANCIAL INC | 277,363 | 0 | 0 | 0 | For |
Institutional-manager reports, all 120 managers: 56,219,653 for, 5,304,982 against, 94 not voted. Showing the 25 largest; see all in the interactive database.
99.9% Approved · of votes cast
Description as filed by funds: The ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026.
Solid Biosciences Inc.’s own tally for this item (“3. The appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026”): 86,420,186 for, 70,007 against — passed, per its Form 8-K filed June 10, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The Company's stockholders ratified the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026.”
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 44 asset managers below reported 13,948,614 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 4,839,219 | 0 | 0 | 0 | For |
| Vanguard | 2,985,494 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 1,595,479 | 0 | 0 | 0 | For |
| BlackRock | 1,532,543 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 1,253,978 | 0 | 0 | 0 | For |
| TIAA | 387,214 | 0 | 0 | 0 | For |
| Invesco | 231,907 | 0 | 0 | 0 | For |
| Charles Schwab | 160,725 | 0 | 0 | 0 | For |
| Equitable | 149,315 | 0 | 0 | 0 | For |
| American Century | 114,392 | 0 | 0 | 0 | For |
| Dimensional | 97,394 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 97,015 | 0 | 0 | 0 | For |
| JPMorgan | 94,041 | 0 | 0 | 0 | For |
| Lincoln Financial | 84,756 | 0 | 0 | 0 | For |
| Northern Trust | 29,404 | 0 | 0 | 0 | For |
| Global X | 28,094 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 27,766 | 0 | 0 | 0 | For |
| Voya | 23,575 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 22,095 | 0 | 0 | 0 | For |
| Pacific Life | 21,916 | 0 | 0 | 0 | For |
| Nationwide | 19,407 | 0 | 0 | 0 | For |
| State Street | 19,329 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 15,000 | 0 | 0 | 0 | For |
| Brighthouse | 14,782 | 0 | 0 | 0 | For |
| Jackson National | 13,761 | 0 | 0 | 0 | For |
Showing the 25 largest of 44 asset managers. See all 44 in the interactive database.
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 98,449,606 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Fidelity | 4.92% |
| 2 | Vanguard | 3.03% |
| 3 | Columbia Threadneedle | 1.62% |
| 4 | BlackRock | 1.56% |
| 5 | FRANKLIN STRATEGIC SERIES | 1.27% |
| 6 | TIAA | 0.39% |
| 7 | Invesco | 0.24% |
| 8 | Charles Schwab | 0.16% |
| 9 | Equitable | 0.15% |
| 10 | American Century | 0.12% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | PERCEPTIVE ADVISORS LLC | 11.23% |
| 2 | RA CAPITAL MANAGEMENT, L.P. | 9.49% |
| 3 | Siren, L.L.C. | 7.81% |
| 4 | Bain Capital Life Sciences Investors, LLC | 4.58% |
| 5 | Fidelity | 3.79% |
| 6 | Deep Track Capital, LP | 3.62% |
| 7 | FRANKLIN ADVISERS INC | 2.71% |
| 8 | Vestal Point Capital, LP | 2.55% |
| 9 | Redmile Group, LLC | 1.98% |
| 10 | BlackRock | 1.83% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.
| Holder | % outstanding | Disclosure |
|---|---|---|
| RA Capital Management, L.P. | 12.23% | 13D |
| Perceptive Life Sciences Master Fund, Ltd. and affiliated entities | 12.16% | DEF14A |
| Entities affiliated with Bain Capital Life Sciences Investors, LLC | 10.58% | DEF14A |
| Invus Public Equities, L.P. and affiliated entities | 10.23% | DEF14A |
| Raymond Debbane | 10.23% | 13G |
| Entities affiliated with RA Capital Management, L.P. | 10.08% | DEF14A |
| Entities associated with Vestal Point Capital, LP | 9.61% | DEF14A |
| BCLS II Investco, LP | 8.74% | 13D |
| BlackRock | 5.04% | 13F |
| Vestal Point Capital, LP | 4.91% | 13G |
Percentages above are of 98,449,606 shares outstanding, as reported by Solid Biosciences Inc. on its Form 10-Q dated May 8, 2026 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Solid Biosciences Inc.’s 10-Q dated May 8, 2026. This page is a static snapshot rebuilt weekly on October 25, 2026; a live search always shows the current data.
At Solid Biosciences Inc.'s shareholder meeting held June 10, 2026, in the 2025-2026 proxy season, 150 asset managers reported how they voted on 7 ballot items in their SEC Form N-PX filings, covering 971 separate fund positions. On the most widely held item on that ballot — THE APPROVAL OF AN ADVISORY VOTE ON EXECUTIVE COMPENSATION. — Solid Biosciences Inc.'s filing reports the proposal as approved, with 92% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: Solid Biosciences Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 10, 2026.
Solid Biosciences Inc. proxy season coverage: 2024-2025 · 2025-2026 (this page).
Download data (CSV): ballot items · votes by manager · column guide.